biote Corp.

biote Corp. (Nasdaq: BTMD) is a hormone optimization company that completed its de-SPAC business combination with Haymaker Acquisition Corp. III, sponsored by Haymaker Sponsor III LLC, and began trading as a combined public entity in 2022 following the SPAC's 2021 IPO. Operating in the healthcare and wellness sector, biote provides hormone optimization therapy services through a network of certified practitioners across the United States. On May 19, 2023, the company submitted an 8-K current report to the SEC under accession number 0001193125-23-149442, disclosing a material event to investors. For complete filing history, ownership data, and deal analytics on BTMD and thousands of other SPAC transactions, create your free account at SpacDesk.